Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-04-11

FDA Approved: ALPRAZOLAM — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for alprazolam submitted by Aurobindo Pharma Limited under an ANDA. This action indicates approval of a supplement relat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alprazolam (alprazolam)

Snippet

SUPPL AP for ALPRAZOLAM (ALPRAZOLAM)